期刊文献+

急性冠脉综合征早期治疗策略的选择

Selection of Early Treatment Strategy for Acute Coronary Syndrome
下载PDF
导出
摘要 急性冠脉综合征是临床中最常见的心血管急症之一,具有发病急、病情变化快及死亡率高等特点。争取及早实施抢救治疗,可大大降低其死亡率。现就急性冠脉综合征的早期治疗(即发病24 h之内)包括保守治疗和介入性治疗在非ST段抬高和ST段抬高的急性冠脉综合征的治疗策略作如下综述。 Acute coronary syndrome is one of the most familiar cardiovascular emergencies in the hospital.With the development of the event,the patient's condition changes rapid and the mortality increases.Rapid response or care reduces the risk of mortality.This article introduces early treatment strategies(the development of disease is less than 24 hours) including expected treatments and invasive treatments.
出处 《心血管病学进展》 CAS 2010年第6期836-839,共4页 Advances in Cardiovascular Diseases
基金 新疆自治区重大科技专项课题(200733146-3)
关键词 急性冠脉综合征 早期 治疗策略 acute coronary syndrome early treatment strategy
  • 相关文献

参考文献23

  • 1Felipe M.Glycoprotein Ⅱb/Ⅲa inhibitors in clinical practice[J].Arq Bras Cardiol,2009,92(1):65-73.
  • 2Leszek B,Agnieszka P,Michal Z,et al.Dual antiplatelet therapy and antithrombotic treatment:recommendations and controversies[J].Cardiol J,2009,2(16):179-189.
  • 3Valgimigli M,Campo G,de Cesare N,et al.Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R).Rationale for the study and protocol design[J].Cardiovasc Drugs Ther,2008,22(4):313-320.
  • 4Gibson CM,Morrow DA,Murphy SA,et al.A randomized trail to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction,ischemia and inflammation among antiplatelet agents.The PROTECT-TIMI-30 trail[J].J Am Coll Cardiol,2006,47(12):2364-2373.
  • 5Peters RJ,Joyner C,Bassand JP,et al.The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction:a subgroup analysis of the OASIS-6 trial[J].Eur Heart J,2008,29(3):324-331.
  • 6Antman EM,Hard M,Armstrong PW,et al.2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practive Guidelines:developed in collaboration with the Canadial Cardiovascular Society endorsed by the American Academy of Family physicians:2007 Writing Group to Review New Evidence and Update the 2004 guidelines for the management of patients with ST-elevation myocardial infarction Writing on Behalf of the 2004 Writing Committee[J].Circulation,2008,117(2):296-329.
  • 7van de Werf F,Bax J,Betriu A,et al.Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation:the Task Force on the management ST-segment elevation acute myocardial infarction of the European Society of Cardiology[J].Eur Heart J,2008,29(23):2909-2945.
  • 8Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practive Guidelines(Writing committee to Revise the 1999 Guidelines for the management of patients with Acute Myocardial Infarction)[J].Circlulation,2004,110(5):588-636.
  • 9Li JJ,Li YS,Zhang Y,et al.Inflammation:a possible pathogenic link to cardic syndrome[J].Med Hypotheses,2006,66(8):87-91.
  • 10di Sciascio G,Patti G,Pasceri V,et al.Efficacy of atorvastatin reload in patients on chornic statin therapy underloading percutaneous coronary interventions:results of the ARMYDA-RECAPTURE(Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomised trail[J].J Am Coll Cardiol,2009,54(6):558-565.

二级参考文献7

  • 1Giuseppe DL, Harry S, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction.Circulation, 2004, 109.. 1223-1225.
  • 2Eagle KA, Goodman SG, Avecum A, et al. Practice variation and missed opportunities for reperfusian in ST-segment elevation myocardial infarction - findings from the Global Registry of Acute Coronary Events(GRACE). Lancet, 2002,359: 373-377.
  • 3Tamis-Holland JE, Palazzo A, Stebbins AL, et al. Benefits of direct angioplasty for women and man with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO H -B) Angioplasty Substudy.Am Heart J, 2004,147:133-139.
  • 4Giuseppe DL, Harry S, Felix Z, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coil Cardiol, 2003,42:991-997.
  • 5Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.JAMA, 2000,283:2941-2947.
  • 6Andersen HR., Nielsen TY, Rasmussen K, et al. Long distance transport for PCI vs immediate fibrinolysis in acute MI. DANAMI-2. N Engl J Med, 2002,349:733-742.
  • 7Grines CL, Westerhauson DR, Grines LL, et al. Transfer for primary PCI vs on site fibrinolysis in high risk ST-elevation MI patients. AIR PAM1. J Am Coil Cardiol, 2002,39:1713-1719.

共引文献4989

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部